Research/art/teacher profile of a person
Name and surname:
Mgr. Veronika Holubeková, PhD.
Document type:
Research/art/teacher profile of a person
The name of the university:
Comenius University Bratislava
The seat of the university:
Šafárikovo námestie 6, 818 06 Bratislava

I. - Basic information

I.1 - Surname
Holubekova
I.2 - Name
Veronika
I.3 - Degrees
Mgr. PhD.
I.4 - Year of birth
1985
I.5 - Name of the workplace
Biomedical centre Martin, Jessenius faculty of medicine CU in Martin
I.6 - Address of the workplace
Malá Hora 4D, 036 01 Martin
I.7 - Position
Researcher, class IIa
I.8 - E-mail address
veronika.holubekova@uniba.sk
I.9 - Hyperlink to the entry of a person in the Register of university staff
https://www.portalvs.sk/regzam/detail/18047
I.11 - ORCID iD
https://orcid.org/0000-0002-5979-8358

II. - Higher education and further qualification growth

II.1 - First degree of higher education
II.a - Name of the university or institution
Faculty of natural sciences CU in Bratislava
II.b - Year
2004 - 2007
II.c - Study field and programme
Biology
II.2 - Second degree of higher education
II.a - Name of the university or institution
Faculty of natural sciences CU in Bratislava
II.b - Year
2007 - 2009
II.c - Study field and programme
Virology
II.3 - Third degree of higher education
II.a - Name of the university or institution
Jessenius faculty of medicine CU in Martin
II.b - Year
2009 - 2013
II.c - Study field and programme
Gynaecology and obstetrics
II.4 - Associate professor
II.5 - Professor
II.6 - Doctor of Science (DrSc.)

III. - Current and previous employment

III.a - Occupation-position III.b - Institution III.c - Duration
Researcher - postdoc Jessenius faculty of medicine CU in Martin 2013 - 2015
Researcher Jessenius faculty of medicine CU in Martin 2017 - 2021
Researcher class IIa Jessenius faculty of medicine CU in Martin 2021 - current

IV. - Development of pedagogical, professional, language, digital and other skills

IV.a - Activity description, course name, other IV.b - Name of the institution IV.c - Year
Professional training for working with highly toxic substances and mixtures and toxic substances and mixtures, Axelum, s.r.o. Axelum, sro 2022

V. - Overview of activities within the teaching career at the university

V.1 - Overview of the profile courses taught in the current academic year according to study programmes
V.2 - Overview of the responsibility for the delivery, development and quality assurance of the study programme or its part at the university in the current academic year
V.3 - Overview of the responsibility for the development and quality of the field of habilitation procedure and inaugural procedure in the current academic year
V.4 - Overview of supervised final theses
V.4.1 - Number of currently supervised theses
V.4.2 - Number of defended theses
V.5 - Overview of other courses taught in the current academic year according to study programmes

VI. - Overview of the research/artistic/other outputs

VI.1 - Overview of the research/artistic/other outputs and the corresponding citations
VI.1.1 - Number of the research/artistic/other outputs
VI.1.a - Overall
120
VI.1.b - Over the last six years
30
VI.1.2 - Number of the research/artistic/other outputs registered in the Web of Science or Scopus databases
VI.1.a - Overall
44
VI.1.b - Over the last six years
27
VI.1.3 - Number of citations corresponding to the research/artistic/other outputs
VI.1.a - Overall
453
VI.1.b - Over the last six years
270
VI.1.4 - Number of citations registered in the Web of Science or Scopus databases
VI.1.a - Overall
416
VI.1.b - Over the last six years
260
VI.1.5 - Number of invited lectures at the international, national level
VI.2 - The most significant research/artistic/other outputs
1

Fiolka, Roman, Žúbor, Pavol, Holubeková, Veronika, Višňovský, Jozef, Hornáková, Andrea, Kajo, Karol, Lasabová, Zora, Plank, Lukáš, Danko, Ján. Promoter hypermethylation of the tumor-suppressor genes RASSF1A, GSTP1 and CDH1 in endometrial cancer. Oncology Reports, 2013, roč. 30, č. 6 (2013), s. 2878-2886.

2

Holubeková, Veronika, Hornáková, Andrea, Grendár, Marián, Meršaková, Sandra, Chmúrna, Ivana, Jašek, Karin, Vaňochová, Andrea, Danko, Ján, Lasabová, Zora. Methylation pattern of CDH1 promoter and its association with CDH1 gene expression in cytological cervical specimens. Oncology Letters, 2016, roč. 12, č. 4, s. 2613-2621.

3

Holubeková, Veronika, Hornáková, Andrea, Jašek, Karin, Meršaková, Sandra, Žúbor, Pavol, Lasabová, Zora. Epigenetic regulation by DNA methylation and miRNA molecules in cancer. Future Oncology, 2017, roč. 13, č. 25, s. 2217-2222.

4

Meršaková, Sandra, Holubeková, Veronika, Grendár, Marián, Višňovský, Jozef, Ňachajová, Marcela, Kalman, Michal, Kúdela, Erik, Žúbor, Pavol, Bielik, Tibor, Lasabová, Zora, Danko, Ján. Methylation of CADM1 and MAL together with HPVstatus in cytological cervical specimens serves an important role in the progression of cervical intraepithelial neoplasia. Oncology Letters, 2018, roč. 16, č. 6, s. 7166-7174.

5

Holubeková, Veronika, Kolková, Zuzana, Grendár, Marián, Braný, Dušan, Dvorská, Dana, Šťastný, Igor, Jagelková, Marianna, Zelinová, Katarína, Samec, Marek, Mazuráková, Alena, Ondák Laučeková, Zuzana, Kúdela, Erik, Bobrovská, Martina, Kalman, Michal, Žúbor, Pavol, Danková, Zuzana. Pathway analysis of selected circulating mirnas in plasma of breast cancer patients: A preliminary study. International journal of molecular sciences , 2020, Roč. 21, č. 19, s. [1-16], no. 7288.

VI.3 - The most significant research/artistic/other outputs over the last six years
1

Holubeková, Veronika, Meršaková, Sandra, Grendár, Marián, Kolková, Zuzana, Kúdela, Erik, Kalman, Michal, Lasabová, Zora, Danko, Ján, Žúbor, Pavol. The Role of CADM1 and MAL Promoter Methylation in Inflammation and Cervical Intraepithelial Neoplasia. Genetic Testing and Molecular Biomarkers, 2020, roč. 24, č. 5, s. 256-263.

2

Kolková, Zuzana, Holubeková, Veronika, Grendár, Marián, Ňachajová, Marcela, Žúbor, Pavol, Pribulová, Terézia, Loderer, Dušan, Žigo, Imrich, Biringer, Kamil, Hornáková, Andrea. Association of Circulating miRNA Expression with Preeclampsia, Its Onset, and Severity. Diagnostics, 2021, roč. 11, č. 3, s. [1-15].

3

Kúdelová, Eva, Holubeková, Veronika, Grendár, Marián, Kolková, Zuzana, Samec, Marek, Váňová, Barbora, Mikolajčík, Peter, Smolár, Marek, Kúdela, Erik, Laca, Ľudovít, Lasabová, Zora. Circulating miRNA expression over the course of colorectal cancer treatment. Oncology Letters, 2022, roč. 23, č. 1 (2022), s. [1-15], no. 18.

4

Rokos, Tomáš, Holubeková, Veronika, Kolková, Zuzana, Hornáková, Andrea, Pribulová, Terézia, Kozubík, Erik, Biringer, Kamil, Kúdela, Erik. Is the Physiological Composition of the Vaginal Microbiome Altered in High-Risk HPV Infection of the Uterine Cervix? Viruses, 2022, roč. 14, č. 10, s. [1-10], no. 2130.

5

Holubeková, Veronika, Loderer, Dušan, Grendár, Marián, Mikolajčík, Peter, Kolková, Zuzana, Túryová, Eva, Kúdelová, Eva, Kalman, Michal, Marcinek, Juraj, Miklušica, Juraj, Laca, Ľudovít, Lasabová, Zora. Differential gene expression of immunity and inflammation genes in colorectal cancer using targeted RNA sequencing. Frontiers in oncology, 2023, roč. 13, č. Október (2023), s. [1-17].

VI.4 - The most significant citations corresponding to the research/artistic/other outputs
VI.5 - Participation in conducting (leading) the most important research projects or art projects over the last six years
1

09I03-03-V04-00228, Epigenetic changes in the development of cervical cancer, Main researcher: Mgr. Veronika Holubeková, PhD. (Call: Scholarships for excellent R2-R4 researchers)

2

APVV-23-0428: The role of the vaginal microbiome and immune system in the process of HPV-induced cervical carcinogenesis. Main researcher: Prof. MUDr. Erik Kúdela, PhD.

3

ITMS 313011AUA4: New possibilities of laboratory diagnostics and massive screening SARS-COV-2 and identifying the mechanisms of virus behavior in the human body. Operational program Integrated infrastructure. COVLAB.

4

ITMS: 313011AFG5: Systemic public research infrastructure - biobank for cancer and rare diseases. Operational program Integrated Infrastructure 2014-2020. Bioford.

5

ITMS 313011V446: Integrative strategy in the development of personalized medicine of selected malignant cancer and its impact on the quality of life. Operational program Integrated Infrastructure 2014-2020. Lisper.

6

VEGA 1/0269/22, "Study of differential gene expression of immunity genes, inflammation and hypoxia in colorectal cancer." Main researcher: doc. RNDr. Zora Lasabova, PhD.

7

VEGA 1/0398/21, “The immune system and vaginal microbiome as important mediators in the process of cervical carcinogenesis”, Main researcher: doc. MUDr. Erik Kúdela, PhD.

8

VEGA 1/0380/18: Analyzes of methylated DNA sequences in plasma as an universal marker of colorectal carcinoma relapse. Main researcher: doc. RNDr. Zora Lasabova, PhD.

VII. - Overview of organizational experience related to higher education and research/artistic/other activities

VIII. - Overview of international mobilities and visits oriented on education and research/artistic/other activities in the given field of study

IX. - Other relevant facts

Date of last update
2025-02-27